| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13393* | 2021 |
| Integrated genomic analyses of ovarian carcinoma Cancer Genome Atlas Research Network Nature 474 (7353), 609, 2011 | 7006 | 2011 |
| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4707 | 2018 |
| Graphene: the new two‐dimensional nanomaterial CNR Rao, AK Sood, KS Subrahmanyam, A Govindaraj Angewandte Chemie International Edition 48 (42), 7752-7777, 2009 | 4585 | 2009 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 2825 | 2018 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2621 | 2018 |
| Advances and challenges of liposome assisted drug delivery L Sercombe, T Veerati, F Moheimani, SY Wu, AK Sood, S Hua Frontiers in pharmacology 6, 286, 2015 | 2485 | 2015 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2269 | 2018 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 2128 | 2018 |
| MicroRNAs in body fluids—the mix of hormones and biomarkers MA Cortez, C Bueso-Ramos, J Ferdin, G Lopez-Berestein, AK Sood, ... Nature reviews Clinical oncology 8 (8), 467-477, 2011 | 1730 | 2011 |
| Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1706 | 2018 |
| Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast Jr, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011 | 1533 | 2011 |
| Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma PH Thaker, LY Han, AA Kamat, JM Arevalo, R Takahashi, C Lu, ... Nature medicine 12 (8), 939-944, 2006 | 1424 | 2006 |
| The influence of bio-behavioural factors on tumour biology: pathways and mechanisms MH Antoni, SK Lutgendorf, SW Cole, FS Dhabhar, SE Sephton, ... Nature reviews cancer 6 (3), 240-248, 2006 | 1296 | 2006 |
| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015 | 1210 | 2015 |
| Ovarian cancer UA Matulonis, AK Sood, L Fallowfield, BE Howitt, J Sehouli, BY Karlan Nature reviews Disease primers 2 (1), 1-22, 2016 | 1183 | 2016 |
| RNA interference in the clinic: challenges and future directions CV Pecot, GA Calin, RL Coleman, G Lopez-Berestein, AK Sood Nature Reviews Cancer 11 (1), 59-67, 2011 | 968 | 2011 |
| Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239-254. e6, 2018 | 956 | 2018 |
| Genomic and functional approaches to understanding cancer aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ... Cancer cell 33 (4), 676-689. e3, 2018 | 929 | 2018 |
| Dicer, Drosha, and outcomes in patients with ovarian cancer WM Merritt, YG Lin, LY Han, AA Kamat, WA Spannuth, R Schmandt, ... New England Journal of Medicine 359 (25), 2641-2650, 2008 | 907 | 2008 |
